000 01337 a2200385 4500
005 20250516051504.0
264 0 _c20111005
008 201110s 0 0 eng d
022 _a1879-8853
024 7 _a10.1016/j.cger.2011.03.010
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAbellan van Kan, Gabor
245 0 0 _aClinical trials on sarcopenia: methodological issues regarding phase 3 trials.
_h[electronic resource]
260 _bClinics in geriatric medicine
_cAug 2011
300 _a471-82 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Review
650 0 4 _aAged
650 0 4 _aAging
_xphysiology
650 0 4 _aBiomarkers
650 0 4 _aClinical Trials, Phase III as Topic
650 0 4 _aHumans
650 0 4 _aMuscle Strength
_xphysiology
650 0 4 _aMuscle Weakness
_xdrug therapy
650 0 4 _aResearch Design
650 0 4 _aSarcopenia
_xdiagnosis
650 0 4 _aTreatment Outcome
700 1 _aCameron Chumlea, Wm
700 1 _aGillette-Guyonet, Sophie
700 1 _aHoules, Mathieu
700 1 _aDupuy, Charlotte
700 1 _aRolland, Yves
700 1 _aVellas, Bruno
773 0 _tClinics in geriatric medicine
_gvol. 27
_gno. 3
_gp. 471-82
856 4 0 _uhttps://doi.org/10.1016/j.cger.2011.03.010
_zAvailable from publisher's website
999 _c21069337
_d21069337